For decades, the standard of care for patients with resected stage II and III colon cancer has centred on surgery with consideration of postoperative adjuvant systemic therapy to reduce risk of ...
SEER–Medicare analysis showed persistent adjusted racial gaps in curative-intent treatment for early-stage NSCLC, with Black patients less likely to receive surgery or radiotherapy across 2005–2019.
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA ...
Receiving treatment at an academic center may improve the probability of receiving subsequent curative care among those with hepatocellular carcinoma. Curative treatment conversion (CTC), although ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
The researchers found that lower rates of curative treatment among Black patients versus White patients are driven by lack of receipt of surgical treatment. HealthDay News — Racial disparities persist ...
A new study provides hope that smarter timing of cancer treatments could improve cure rates. The study's Principal Investigator, Dr. Robert Noble, Senior Lecturer at the Department of Mathematics, ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results